Successful treatment of tafro syndrome with tocilizumab, prednisone, and cyclophosphamide

Taku Kikuchi, Takayuki Shimizu, Takaaki Toyama, Ryohei Abe, Shinichiro Okamoto

研究成果: Article査読

5 被引用数 (Scopus)

抄録

TAFRO syndrome is a rare systemic inflammatory disease characterized by thrombocytopenia, pleural effusion, fever, renal dysfunction, reticulin fibrosis of the bone marrow, and organomegaly. The clinical course varies significantly among patients. However, the prognosis is usually dismal in patients with severe TAFRO syndrome, and no optimal treatment has yet been established. We herein describe the first case of TAFRO syndrome, which was successfully treated with combination therapy consisting of tocilizumab, prednisone, and cyclophosphamide.

本文言語English
ページ(範囲)2205-2211
ページ数7
ジャーナルInternal Medicine
56
16
DOI
出版ステータスPublished - 2017

ASJC Scopus subject areas

  • Internal Medicine

フィンガープリント 「Successful treatment of tafro syndrome with tocilizumab, prednisone, and cyclophosphamide」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル